TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sanuwave Health ( (SNWV) ) has provided an announcement.
Sanuwave, Inc. entered into an exclusive license and option agreement on March 6, 2024, with a third-party licensee concerning its patents in the intravascular shockwave applications field. The Licensee exercised its option to acquire the patents on August 21, 2025, resulting in a $5 million cash payment to Sanuwave, Inc., following an initial $2.5 million payment.
The most recent analyst rating on (SNWV) stock is a Hold with a $41.00 price target. To see the full list of analyst forecasts on Sanuwave Health stock, see the SNWV Stock Forecast page.
Spark’s Take on SNWV Stock
According to Spark, TipRanks’ AI Analyst, SNWV is a Neutral.
Sanuwave Health’s overall stock score is driven by strong earnings call performance and positive technical indicators, offset by weak financial performance and unattractive valuation. The company’s revenue growth and product sales are promising, but financial instability and profitability challenges remain significant risks.
To see Spark’s full report on SNWV stock, click here.
More about Sanuwave Health
Average Trading Volume: 84,290
Technical Sentiment Signal: Buy
Current Market Cap: $314.5M
Find detailed analytics on SNWV stock on TipRanks’ Stock Analysis page.